Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-02-05 @ 5:29 PM
Study NCT ID:
NCT06950034
Status:
RECRUITING
Last Update Posted:
2025-04-29
First Post:
2025-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Sponsor:
Solu Therapeutics, Inc
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Myelomonocytic Leukemia | View |
| None | Chronic Myelomonocytic Leukemia (CMML) | View |
| None | Chronic Myelomonocytic Leukemia-1 | View |
| None | Chronic Myelomonocytic Leukemia-2 | View |
| None | Refractory Chronic Myelomonocytic Leukemia | View |
| None | CMML | View |
| None | Acute Myeloid Leukemia | View |
| None | Acute Myeloid Leukemia (AML) | View |
| None | Acute Myeloid Leukemia Post Cytotoxic Therapy | View |
| None | Acute Myeloid Leukemias | View |
| None | Refractory Acute Myeloid Leukemia (AML) | View |
| None | Acute Monocytic Leukemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | refractory/resistant CMML | View |
| None | CMML | View |
| None | AML | View |
| None | monocytic AML | View |
| None | Relapsed/refractory AML | View |
| None | monocytic-predominant AML | View |
| None | Chronic Myelomonocytic Leukemia | View |
| None | Acute Myeloid Leukemia | View |
| None | Refractory Chronic Myelomonocytic Leukemia | View |
| None | Refractory Acute Myeloid Leukemia | View |